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Background: Since the approval of retrievable Inferior Vena Cava (IVC) filters in 2001, their use has dramatically increased as the threshold for 
use has been lowered. Recent studies have shown a disappointing 26% retrieval rate, of which only 74% were successful. To this end, in August 2010, 
the FDA received 921 reports of adverse events, including 328 cases of device migration, 146 of embolization, 70 IVC perforations, and 56 filter 
fractures, which led to a firm recommendation that retrievable IVC filters should only be used as bridge therapy and removed as soon as possible. 
Traditionally, IVC filters have been placed by vascular surgeons and interventional radiologists. We report the safety, long term outcomes, and 
retrieval rates of retrievable IVC filters placed by Interventional Cardiologists with formal vascular training.
Method: A total of 376 patients had retrievable IVC filters placed over a 24-month period (2009-2010). Indications included prior to high risk 
bariatric surgery (96), high risk massive or submassive pulmonary embolism (110), proximal lower extremity Deep Venous Thrombosis (DVT) with 
contraindication or failure of anticoagulation (93), prior to non-bariatric surgery (41), and other hypercoagulable states including malignancy (36). 
There was systematic follow up by a dedicated nurse, which consisted of a phone interview or an office visit.
Results: At the conclusion, a total of 17 patients expired or failed to follow up. Of the remaining 359 IVC filters that were placed, 95 were deemed 
to be permanent clinically. Of the 264 planned retrievable IVC filters, 210 (80%) were attempted to be retrieved. Only 12 (6%) attempts at retrieval 
were unsuccessful. The majority (99.5%) were retrieved within one year of placement.
Conclusion: We have shown in this series of 376 patients that retrievable IVC filter implants done by vascular trained Interventional Cardiologists 
are safe with low complication rates, and higher retrieval rates than historical studies.
